Genomic Valley Biotech Ltd — Important, 03-04-2026: Company Update

Genomic Valley Biotech's promoters, led by Yogesh Agrawal, have declared that neither they nor the broader promoter group or persons acting in concert have pledged or created any encumbrance on their company shares throughout the financial year ended March 31, 2026. This update is significant for stakeholders, as it indicates the promoters' shareholdings are free from pledges. This stability can be seen as a positive sign for the company, implying an absence of immediate financial pressure on the promoter group that would necessitate using their shares as collateral.